Adjuvant Luteinising Hormone-Releasing Hormone (LHRH)--Agonist Therapy in Prostate Cancer

ISSN： 1561-0950

Source： UroOncology, Vol.3, Iss.2, 2003-06, pp. : 51-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Luteinising hormone-releasing hormone antagonists in prostate cancer therapy

By Msaouel Pavlos Diamanti Evanthia Tzanela Marinela Koutsilieris Michael

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 285-299

Informa Healthcare

Access to resources Recommend Favorite

Luteinising hormone releasing hormone analogues in the treatment of prostate cancer

By Gommersall Lyndon M Hayne Dickon Shergill Iqbal S Arya Manit Wallace DMA

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1685-1692

Informa Healthcare

Access to resources Recommend Favorite

Agonists of luteinizing hormone-releasing hormone in prostate cancer

By Rick Ferenc G Block Norman L Schally Andrew V

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2237-2247

Informa Healthcare

Access to resources Recommend Favorite

Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer

By Liu Stephen V Liu Shanshan Pinski Jacek

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 769-778

Informa Healthcare

Access to resources Recommend Favorite

Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer

By Mongiat-Artus Pierre Teillac Pierre

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2171-2179

Informa Healthcare

Access to resources Recommend Favorite